ReviewOncoTargets and therapy2017
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors.
Bilal Zulfiqar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewOncoTargets and therapy2017
Bilal Zulfiqar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.